financetom
Business
financetom
/
Business
/
Factbox-Key elements of EU-U.S. trade deal agreed on Sunday
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Factbox-Key elements of EU-U.S. trade deal agreed on Sunday
Jul 27, 2025 11:36 PM

(Reuters) -The U.S. and the European Union agreed on a framework trade deal on Sunday, ending months of uncertainty for industry and consumers on both sides of the Atlantic.

Here are the main elements of the deal:

* Almost all EU goods entering the U.S. will be subject to a 15% baseline tariff, including cars, which now face 27.5%, as well as semiconductors and pharmaceuticals. The 15% tariff is the maximum tariff and is not added to any existing rates.

* However, the U.S. is to announce the result of its 232 trade investigations in two weeks and decide separately on tariff rates for chips and pharmaceuticals. Whatever U.S. decisions come later on these sectors will be "on a different sheet of paper", European Commission President Ursula von der Leyen said.

* The U.S. and EU will have zero-for-zero tariffs on all aircraft and their components, certain chemicals, certain generic drugs, semiconductor equipment, some agricultural products, natural resources and critical raw materials. More products would be added. The situation for spirits is still to be established.

* Tariffs on European steel and aluminium will stay at 50%, but von der Leyen said these would later be cut and replaced by a quota system.

* The EU pledged to make $750 billion in strategic purchases, covering oil, gas, nuclear, fuel and chips during Trump's term.* Under the deal, the EU pledged to buy U.S. military equipment and European companies are to invest $600 billion in the U.S. over the course of Trump's second term.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bausch + Lomb Closes Floating Rate Note Offering, Refinances Credit Facilities
Bausch + Lomb Closes Floating Rate Note Offering, Refinances Credit Facilities
Jun 26, 2025
05:00 PM EDT, 06/26/2025 (MT Newswires) -- Bausch + Lomb ( BLCO ) closed an upsized offering of 675 million euros ($789.6 million) in senior secured floating rate notes due Jan. 15, 2031. The notes bear interest at the three-month Euro Interbank Offered Rate plus 3.875%, reset quarterly, the company said Thursday in a statement. The company also completed a...
Nike tops Q4 sales, profit estimates as CEO doubles down on sports focus
Nike tops Q4 sales, profit estimates as CEO doubles down on sports focus
Jun 26, 2025
June 26 (Reuters) - Nike ( NKE ) reported a smaller-than-expected drop in fourth-quarter revenue and beat profit estimates on Thursday, as CEO Elliott Hill's strategy to focus product innovation and marketing around sports begins to pay off. The company, which has been grappling with competition in the running space, has heavily invested in running shoes and sneaker lines such...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Achieve Life Sciences Seeks FDA Approval for Smoking Cessation Drug, Partners With Omnicom for Launch
Achieve Life Sciences Seeks FDA Approval for Smoking Cessation Drug, Partners With Omnicom for Launch
Jun 26, 2025
05:00 PM EDT, 06/26/2025 (MT Newswires) -- Achieve Life Sciences ( ACHV ) said Thursday it submitted a new drug application to the US Food and Drug Administration for cytisinicline as a treatment for nicotine dependence in smoking cessation. The application is supported by efficacy and safety data from two phase 3 trials, the company said. Separately, Achieve said it...
Copyright 2023-2026 - www.financetom.com All Rights Reserved